Deusa Cast discusses the update of RDC 660 and access to medicinal cannabis in Brazil
Episode addresses the update of RDC 660, international certification, and challenges to expand access to treatments with different cannabinoids in Brazil.
Published on 02/11/2026
Illustrative Image: Canva Pro
The new episode of Deusa Cast #55 focuses on RDC 660, a regulation that governs the import of medicinal cannabis products in the country and is expected to undergo an update process by Anvisa in 2026.
During the conversation, Dalton Marquez, lawyer and founding partner of Remederi, and Sandro Koen Nogueira, director of Memphis Courrier, discuss the importance of RDC 660 in ensuring broad access to treatments with different cannabinoids in Brazil, as well as the certification and validation of international products, especially from the United States, and the equivalence between different formulations available in the market.
The episode also discusses the logistical and regulatory challenges of importation, the possibilities for greater efficiency in processes, the role of Anvisa in validating international products, and the impacts of these rules on patients, doctors, and companies in the sector.
Another point addressed is the current limitation on access to medicinal cannabis in the country and the possible ways to expand the availability of safe, traceable, and quality-controlled treatments.
